HTA Council Recommendation (as of 18 March 2026) As final recommendation, the HTA Council recommends tissue-based EGFR PCR Mutation Test for the diagnosis of EGFR mutations in patients with non-squamous NSCLC; and, for patients diagnosed with squamous NSCLC aged <50 years old, regardless of smoking history, for government financing. The Council further recommends adherence to the recommended continue reading : Epidermal Growth Factor (EGFR) tests [Tissue-based EGFR PCR Mutation Test] for diagnosis of EGFR mutations in patients with NSCLC
Moderate Complexity Nucleic Acid Amplification Tests (NAATS) for the diagnosis of Multi-drug Resistant Tuberculosis (MDR-TB) with isoniazid (INH) and rifampicin (RIF) resistance testing
HTA Council Recommendation (as of 01 December 2025) As a final recommendation, the HTA Council recommends moderate complexity NAATs for the diagnosis of MDR-TB with INH and RIF resistance testing, for financing of DOH and/or PhilHealth. Relevant Information Evidence and Relevant Documents Assessment History Back to Assessments Page
Chip-based RT-PCR MTB-RIF test for screening or diagnosis of multidrug-resistant tuberculosis (MDR-TB)
HTA Council Recommendation (as of 9 July 2025) The HTA Council positively recommends the government financing of Chip-based RT-PCR MTB-RIF test for screening or diagnosis of multidrug-resistant tuberculosis (MDR-TB) The HTA Council recommends that the Department of Health refer to existing and future WHO target product profiles (TPPs) when selecting tests for procurement. In the continue reading : Chip-based RT-PCR MTB-RIF test for screening or diagnosis of multidrug-resistant tuberculosis (MDR-TB)
Newborn Pulse Oximetry as a screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns
HTA Council Recommendation (as of 09 July 2025) The HTA Council positively recommends newborn pulse oximetry as a screening test for CCHD among asymptomatic, apparently healthy newborns for financing of DOH and/or PhilHealth. In addition to this, the HTA Council recommends that the Department of Health refer to the WHO-UNICEF technical specifications when selecting the continue reading : Newborn Pulse Oximetry as a screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns
HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester
HTA Council Recommendation (as of 18 June 2025) The HTA Council positively recommends the government financing of HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester The HTA Council strongly recommends that implementation of HIV health technologies should follow the WHO continue reading : HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester